This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of biologically active molecules. Its structure is particularly valuable in the development of potential therapeutic agents, especially in the design of enzyme inhibitors. The trifluoromethyl groups enhance the compound's binding affinity and metabolic stability, making it suitable for targeting specific proteins or receptors involved in disease pathways. Additionally, the chiral cyclohexyl moiety contributes to its selectivity in interacting with biological targets, which is crucial for optimizing drug efficacy and reducing off-target effects. Researchers often employ this compound in the study of central nervous system disorders, cancer, and inflammatory diseases due to its ability to modulate critical signaling pathways. Its unique properties also make it a candidate for further optimization in drug discovery programs aimed at creating novel treatments with improved pharmacokinetic profiles.